Skip to main content
. 2015 May;10(5):814–818. doi: 10.4103/1673-5374.156988

Table 2.

Comparison of the age, gender, or daily dose of patients with or without peripheral neuropathy after thalidomide treatment

graphic file with name NRR-10-814-g002.jpg